These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 721836)

  • 1. Antibody response in humans after administration of whole-virion and split vaccine prepared from two different influenza A/swine viruses.
    Závadová H; Vonka V; Domorázková E; Syrůcek L; Stárek M; Hrusková J; Plesník V; Janout V; Uvízl M
    J Biol Stand; 1978 Jul; 6(3):173-9. PubMed ID: 721836
    [No Abstract]   [Full Text] [Related]  

  • 2. Secretory antibody response to haemagglutinin of influenza virus A/swine and A/victoria in humans after administration of split and whole-virion vaccine.
    Hrusková J; Syrůcek L; Záradová H; Vonka V; Plesník V; Heinz F; Stárek M; Domorázková E
    J Biol Stand; 1978 Jul; 6(3):181-5. PubMed ID: 721837
    [No Abstract]   [Full Text] [Related]  

  • 3. Characteristic of humoral response of elderly to inactivated influenza vaccine.
    Siennicka J
    Arch Immunol Ther Exp (Warsz); 1996; 44(5-6):389-94. PubMed ID: 9017157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody response in four animal species to two different influenza A/swine viruses.
    Dolezalová B; Závadová H; Stárek M; Vonka V
    J Biol Stand; 1978 Jul; 6(3):165-71. PubMed ID: 721835
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibody responses to inactivated influenza vaccines and partial protective effect of anti-neuraminidase antibody against epidemics of A(H3N2) and A(H1N1) influenza.
    Maeda A; Oishi I; Minekawa Y; Kunita N; Funahashi S; Yagura H
    Biken J; 1979 Sep; 22(3):91-8. PubMed ID: 533537
    [No Abstract]   [Full Text] [Related]  

  • 6. Antigenicity and immunogenicity of experimental equine influenza ISCOM vaccines.
    Mumford JA; Jessett D; Dunleavy U; Wood J; Hannant D; Sundquist B; Cook RF
    Vaccine; 1994 Jul; 12(9):857-63. PubMed ID: 7975864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The specificity of serum antibodies to the haemagglutinin of influenza B viruses induced by vaccination.
    Creţescu L; Ioniţă E; Niculescu IT; Coban V; Bogdan C
    Arch Roum Pathol Exp Microbiol; 1987; 46(1):27-33. PubMed ID: 3324992
    [No Abstract]   [Full Text] [Related]  

  • 8. Serological response to whole, split and subunit influenza vaccines of persons with and without immunological experience towards influenza A/U.S.S.R. 90/77 virus.
    Sarateanu DE; Ehrengut W; Pressler K; Peukert M; Schenk KD
    Comp Immunol Microbiol Infect Dis; 1980; 3(1-2):225-36. PubMed ID: 7471712
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative antigenicity and immunogenicity of A/USSR/77 influenza vaccines in normal and primed mice.
    McLaren C; Grubbs GE; Staton E; Barthlow W; Quinnan G; Ennis FA
    Infect Immun; 1980 Apr; 28(1):171-7. PubMed ID: 7380562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influenza vaccine stimulation of antibodies to different variants of influenza A virus].
    Naĭkhin AN; Ispolatova AV; Tsybul'skaia NV; Sominina AA; Denisov GM
    Vopr Virusol; 1985; 30(3):290-6. PubMed ID: 4049840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune response of adults to sequential influenza vaccination.
    Powers RD; Hayden FG; Samuelson J; Gwaltney JM
    J Med Virol; 1984; 14(2):169-75. PubMed ID: 6491643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variant-specific antihemagglutinin serum response to type A influenza natural infection and inactivated vaccines in adults.
    Kasel JA; Six HR; Couch RB; Greenberg SB; Cate TR
    Proc Soc Exp Biol Med; 1979 Sep; 161(4):519-21. PubMed ID: 90369
    [No Abstract]   [Full Text] [Related]  

  • 13. Time to peak serum antibody response to influenza vaccine.
    Rastogi S; Gross PA; Bonelli J; Dran S; Levandowski RA; Russo C; Weksler ME; Kaye D; Levison M; Abrutyn E
    Clin Diagn Lab Immunol; 1995 Jan; 2(1):120-1. PubMed ID: 7719904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphology and antigenicity studies on reassortant influenza (H3N2) viruses for use in inactivated vaccines.
    Pemberton RM; Jennings R; Smith TL
    J Hyg (Lond); 1985 Apr; 94(2):229-39. PubMed ID: 2580887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of immunogenicity of a whole virion and a subunit influenza vaccine in adults.
    Ortbals DW; Liebhaber H
    J Clin Microbiol; 1978 Oct; 8(4):431-4. PubMed ID: 721947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody and cytotoxic T lymphocyte responses of humans to live and inactivated influenza vaccines.
    Ennis FA; Yi-Hua Q; Schild GC
    J Gen Virol; 1982 Feb; 58(Pt 2):273-81. PubMed ID: 7038041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A universal problem.
    Hoag H
    Nat Med; 2013 Jan; 19(1):12-4. PubMed ID: 23295998
    [No Abstract]   [Full Text] [Related]  

  • 18. The specificity of the anti-haemagglutinin antibody response induced in man by inactivated influenza vaccines and by natural infection.
    Oxford JS; Schild GC; Potter CW; Jennings R
    J Hyg (Lond); 1979 Feb; 82(1):51-61. PubMed ID: 105040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of the immunogenicity of trivalent inactivated whole-virion influenza vaccine in human volunteers.
    Moffat MA; Pennington TH; Robertson AM; van Voorthuizen WF
    J Biol Stand; 1982 Apr; 10(2):83-90. PubMed ID: 7096364
    [No Abstract]   [Full Text] [Related]  

  • 20. Reactogenicity and immunogenicity of three inactivated influenza virus vaccines in children.
    Miles RN; Potter CW; Clark A; Jennings R
    J Biol Stand; 1981 Oct; 9(4):379-91. PubMed ID: 7320021
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.